In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller-Hinton Agar Plates.


Journal

Mycopathologia
ISSN: 1573-0832
Titre abrégé: Mycopathologia
Pays: Netherlands
ID NLM: 7505689

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 05 03 2019
accepted: 02 07 2019
pubmed: 13 7 2019
medline: 7 3 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

Trichophyton rubrum and Trichophyton mentagrophytes spp. are two of the most frequently isolated dermatophytes causing dermatophytosis worldwide. Since the incidence of resistance to antifungal agents is increasing, antifungal susceptibility tests are needed to successfully treat dermatophytoses. Most of the methods currently available are complicated, time-consuming and lack of reference procedures. The aim of this work was to establish a simple protocol to test the susceptibility of dermatophytes isolated from clinical samples against five antifungal drugs using E-test and disk diffusion methods. We used the E-test on non-supplemented Mueller-Hinton agar plates to determine the minimum inhibitory concentrations (MICs) of fluconazole, itraconazole, voriconazole and amphotericin B, and disk diffusion method to determine the interpretive MIC of terbinafine. Fifty dermatophytes-10 T. rubrum and 40 T. mentagrophytes spp.-were assessed after only 96 h of colony growth. Terbinafine was the most active antifungal agent with an inhibition diameter greater than 70 mm (sensitivity > 20 mm), followed by voriconazole, itraconazole and amphotericin B with MICs ranging from 0.032 to 0.38 µg/mL, from 0.006 to 0.125 µg/mL and from 0.5 to 1.5 µg/mL, respectively. All isolates were resistant to fluconazole. Collectively, the less laborious E-test and disk diffusion method were shown to be suitable and reliable to determine antifungal sensitivity of dermatophytes. This simple standard protocol could be employed in the routine of clinical laboratories.

Identifiants

pubmed: 31297668
doi: 10.1007/s11046-019-00360-9
pii: 10.1007/s11046-019-00360-9
doi:

Substances chimiques

Antifungal Agents 0
Culture Media 0
Agar 9002-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

517-523

Références

Antimicrob Agents Chemother. 2003 Jan;47(1):82-6
pubmed: 12499173
Med Mycol. 2003 Apr;41(2):125-30
pubmed: 12964844
J Clin Microbiol. 2004 Jul;42(7):2977-9
pubmed: 15243047
Rev Iberoam Micol. 2005 Jun;22(2):110-3
pubmed: 16107170
Diagn Microbiol Infect Dis. 2007 Mar;57(3):273-6
pubmed: 17141455
Arch Dermatol Res. 2007 May;299(2):107-9
pubmed: 17333224
J Med Microbiol. 2007 Apr;56(Pt 4):514-8
pubmed: 17374893
Med Mycol. 2008 Mar;46(2):119-23
pubmed: 18324490
Mycoses. 2008 Sep;51 Suppl 4:2-15
pubmed: 18783559
BMC Res Notes. 2009 Apr 18;2:60
pubmed: 19374765
Clin Infect Dis. 2009 Dec 1;49(11):1749-55
pubmed: 19857164
Med Mycol. 2009 Nov;47(7):753-8
pubmed: 19888808
Curr Opin Infect Dis. 2012 Apr;25(2):126-34
pubmed: 22248981
Med Mycol. 2013 Jan;51(1):17-24
pubmed: 22574631
Antimicrob Agents Chemother. 2013 Nov;57(11):5767-70
pubmed: 23979756
Eurasian J Med. 2014 Feb;46(1):26-31
pubmed: 25610290
J Clin Microbiol. 2015 Oct;53(10):3176-81
pubmed: 26202113
Indian J Med Microbiol. 2015 Oct-Dec;33(4):533-7
pubmed: 26470960
Mycopathologia. 2017 Feb;182(1-2):183-192
pubmed: 27734185
Mycopathologia. 2017 Feb;182(1-2):77-86
pubmed: 27783316
Mycopathologia. 2017 Feb;182(1-2):5-31
pubmed: 27783317
J Clin Microbiol. 2017 Feb;55(2):369-379
pubmed: 27807151
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28416557
Mycoses. 2018 Jul;61(7):477-484
pubmed: 29577447
Indian Dermatol Online J. 2018 Mar-Apr;9(2):120-122
pubmed: 29644200
Lett Appl Microbiol. 2018 Aug;67(2):136-143
pubmed: 29679385
J Fungi (Basel). 2019 Feb 22;5(1):null
pubmed: 30813287

Auteurs

Jari Intra (J)

Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, University of Milano-Bicocca, Via Mazzini 1, 20833, Desio, MB, Italy. j.intra@asst-monza.it.

Cecilia Sarto (C)

Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, University of Milano-Bicocca, Via Mazzini 1, 20833, Desio, MB, Italy.

Selene Mazzola (S)

Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, University of Milano-Bicocca, Via Mazzini 1, 20833, Desio, MB, Italy.

Chiara Fania (C)

Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, University of Milano-Bicocca, Via Mazzini 1, 20833, Desio, MB, Italy.

Natalia Tiberti (N)

Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar, Verona, Italy.

Paolo Brambilla (P)

Department of Laboratory Medicine, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, Desio Hospital, University of Milano-Bicocca, Via Mazzini 1, 20833, Desio, MB, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH